Peter Berglund

Peter Berglund

Auto-generated profile, based on publicly available information

Peter Berglund

Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Brain Injury
Verified
Journal Article
Closed access
PDF file
BJBirgitta Johansson
Birgitta Johansson
PBPeter Berglund
Peter Berglund
LRLars Rönnbäck
Lars Rönnbäck
Primary objective: Mental fatigue is a common symptom after brain injury. Its mechanisms are not fully understood and it has been difficult to find an objective way of measuring it. The aim was to compare cognitive tests with a new self-assessment questionnaire about mental fatigue. Methods and procedures: Individuals reporting mental fatigue for 6 months or more after mild traumatic brain injury (MTBI) or traumatic brain injury (TBI) and controls were assessed for subjective fatigue, information processing speed, working memory and attention. Depression and anxiety were also assessed in the individuals with brain injury. Results: Individuals with MTBI or TBI reported significantly more problems with mental fatigue and related symptoms than controls. A significantly decreased information processing speed (digit symbol-coding, reading speed, trail making test) was found in those on sick leave due to MTBI or TBI, compared to controls. Divided attention was affected to a lesser extent and no effect was detected on working memory. Conclusion: Mental fatigue after MTBI can last for several years. It can be profoundly disabling and affect working capacity as well as social activities. Subjective mental fatigue following brain injury is suggested to mainly correlate with objectively measured information processing speed.

10 December 2009 in Brain Injury
Verified
Journal Article
Closed access
PDF file
BJBirgitta Johansson
Birgitta Johansson
ASAnders Starmark
Anders Starmark
PBPeter Berglund
Peter Berglund
MRMartin Rödholm
Martin Rödholm
LRLars Rönnbäck
Lars Rönnbäck
Primary objective: The purpose was to evaluate a new self-reporting scale for assessment of mental fatigue and its usefulness in describing mental fatigue after neurological diseases and injuries. Mental fatigue is suggested to comprise a spectrum of items including sensory, emotional and cognitive symptoms. Methods and procedures: Mental fatigue and related symptoms were measured with a self-assessment scale on different diagnostic groups with neurological injuries and diseases as well as healthy controls. The scale covers sleep, sensory, emotional and cognitive domains, mental recovery and 24-hour variation. Results: There were significant correlations between all the questions in the self-assessing scale and also a high internal consistency among items (Cronbach's alpha of 0.944). Despite the different aetiologies of mental fatigue and related symptoms, the individuals rated the questions in a similar way. The total sum of scores, as well as the separate questions showed significantly lower values for healthy controls compared to mental fatigue groups. Conclusion: In spite of the different aetiology of mental fatigue, the items included in the scale were significant for different diseases with co-occurring mental fatigue. The self-reported scale is suggested to be a valuable tool for assessment of mental fatigue in different diagnoses.

1 September 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
OROskar Ragnarsson
Oskar Ragnarsson
PBPeter Berglund
Peter Berglund
DEDerek N. Eder
Derek N. Eder
GJGudmundur Johannsson
Gudmundur Johannsson
Cognitive function is impaired in patients with active Cushing's syndrome (CS). The aim was to study cognitive function in patients with CS in long-term remission. We conducted a cross-sectional, case-controlled, single center study. Fifty-five patients previously treated for Cushing's disease (n = 43) and cortisol-producing adrenal adenoma (n = 12) and 55 controls matched for age, gender, and educational level participated in the study. Working memory, attention, information-processing speed, verbal fluency, and reading speed were studied using standardized neuropsychological testing and alerting, orienting, and executive control using the Attentional Network Test. Fatigue impact scale and the comprehensive psychopathological rating scale were used to evaluate fatigue and affective disorder. Median (interquartile range) duration of remission was 13 (5-19) yr and the mean ± SD age at follow-up was 54 ± 14 yr. Compared to controls, patients had a higher score on the fatigue impact scale, indicating greater burdens of fatigue, and a higher score on the comprehensive psychopathological rating scale subscales for depression and anxiety. In a multivariate analysis, attention, spatial orienting, alerting, working memory, verbal fluency, and reading speed were all diminished in comparison to controls, independent of scores for affective disorder and fatigue. No overall difference in outcome was seen between patients in long-term remission for Cushing's disease and cortisol-producing adrenal adenoma. Patients with CS in remission have impaired cognitive function that cannot be explained by the coexistence of affective disorder or chronic fatigue. The pattern of cognitive and attentional deficits suggests a more global involvement of the brain function than has previously been suggested.

1 September 2014 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
OROskar Ragnarsson
Oskar Ragnarsson
CGCamilla A.M. Glad
Camilla A.M. Glad
PBPeter Berglund
Peter Berglund
RBRagnhildur Bergthorsdottir
Ragnhildur Bergthorsdottir
DEDerek N. Eder
Derek N. Eder
GJGudmundur Johannsson
Gudmundur Johannsson
Cognitive function is impaired in patients with Cushing's syndrome (CS) in remission. The objective of the investigation was to study the effects of polymorphisms in genes associated with glucocorticoid (GC) sensitivity on cognitive function in patients with CS in long-term remission. This was a cross-sectional, case-controlled, single-center study. Fifty-three patients with CS in remission and 53 controls matched for age, gender, and educational level participated in the study. Cognitive function, studied using standardized neuropsychological testing, and polymorphisms in the GC receptor (NR3C1; Bcl1 and A3669G), mineralocorticoid receptor (NR3C2; I180V), 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1; rs11119328), and ATP binding cassette B1 (ABCB1; rs1045642) genes were measured. The association between cognitive function and polymorphisms were analyzed using linear regression with adjustments for age and educational level. The mean age in patients and controls was 53 ± 14 years. The median (interquartile range) duration of remission was 13 (5-18) years. In patients, the single-nucleotide polymorphism rs11119328 was associated with impairments in processing speed, auditory attention, auditory working memory, and reading speed. This association was not seen in matched controls. The Bcl1 polymorphism was associated with fatigue and worse visual attention and working memory. The remaining single-nucleotide polymorphisms were not associated with cognitive performance. In this study, polymorphisms in the 11βHSD1 and NR3C1 genes were associated with impaired cognitive function, indicating that GC sensitivity and prereceptor regulation of GC action may play a role in the long-term consequences of CS. The study provides a novel insight into the etiology of cognitive dysfunction in patients with CS in remission.

28 June 2015 in Behavioural Neurology
Verified
Journal Article
Open access
PDF file
EPEleni Papakokkinou
Eleni Papakokkinou
BJBirgitta Johansson
Birgitta Johansson
PBPeter Berglund
Peter Berglund
OROskar Ragnarsson
Oskar Ragnarsson
Patients with Cushings syndrome (CS) in remission often suffer from impaired quality of life and cognitive dysfunction. The primary aim was to investigate the occurrence of mental fatigue, characterized by mental exhaustion and long recovery time following mentally strenuous tasks, in patients with CS in remission. The secondary aim was to examine whether the newly developed parts C and D of the trail making test (TMT) are more sensitive, compared to the conventional parts A and B, to evaluate attention and executive function. This was a cross-sectional study including 51 patients with CS in remission and 51 controls. All subjects completed the self-administrated mental fatigue scale (MFS) and performed all four parts of the TMT. The patients had worse outcome on all components of the MFS except for sensitivity to noise. After adjustment for mental fatigue, depression, and anxiety, the patients performed worse only on part D of the TMT (). Mental fatigue is common in patients with CS in remission and can be captured by using the MFS. The most demanding part of the TMT, part D, is more useful to capture cognitive deficits in patients with CS in remission compared to the conventional parts A and B.

1 July 1996 in Genomics
Verified
Journal Article
Closed access
JSJanos Sumegi
Janos Sumegi
JWJi- Yi Wanga
Ji- Yi Wanga
DZDong- Kai Zhena
Dong- Kai Zhena
JEJames D. Eudy
James D. Eudy
CTCatherine B. Talmadge
Catherine B. Talmadge
WKWilliam J. Kimberling
William J. Kimberling